BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20547981)

  • 1. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
    Asmar M; Simonsen L; Madsbad S; Stallknecht B; Holst JJ; Bülow J
    Diabetes; 2010 Sep; 59(9):2160-3. PubMed ID: 20547981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
    Asmar M; Simonsen L; Arngrim N; Holst JJ; Dela F; Bülow J
    Int J Obes (Lond); 2014 Feb; 38(2):259-65. PubMed ID: 23736366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss.
    Asmar M; Arngrim N; Simonsen L; Asmar A; Nordby P; Holst JJ; Bülow J
    Nutr Diabetes; 2016 May; 6(5):e208. PubMed ID: 27136446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans.
    Asmar M; Simonsen L; Asmar A; Holst JJ; Dela F; Bülow J
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3155-62. PubMed ID: 27258938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor.
    Asmar M; Asmar A; Simonsen L; Gasbjerg LS; Sparre-Ulrich AH; Rosenkilde MM; Hartmann B; Dela F; Holst JJ; Bülow J
    Diabetes; 2017 Sep; 66(9):2363-2371. PubMed ID: 28667118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue.
    Pivovarova O; Gögebakan O; Osterhoff MA; Nauck M; Pfeiffer AF; Rudovich N
    Regul Pept; 2012 Nov; 179(1-3):29-32. PubMed ID: 22960196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characteristics of human subcutaneous abdominal adipose tissue after overnight fast.
    Frayn KN; Humphreys SM
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(4):E468-75. PubMed ID: 22167523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIP-induced vasodilation in human adipose tissue involves capillary recruitment.
    Asmar M; Asmar A; Simonsen L; Dela F; Holst JJ; Bülow J
    Endocr Connect; 2019 Jun; 8(6):806-813. PubMed ID: 31063975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
    Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics.
    Karstoft K; Mortensen SP; Knudsen SH; Solomon TP
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E426-33. PubMed ID: 25564476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men.
    Jocken JW; Goossens GH; van Hees AM; Frayn KN; van Baak M; Stegen J; Pakbiers MT; Saris WH; Blaak EE
    Diabetologia; 2008 Feb; 51(2):320-7. PubMed ID: 18060661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
    Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
    Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
    Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.